Drug intelligence / Profile preview

oxycodone

Development stage
Approved
Lead developer
Purdue Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Oxycodone is a semi-synthetic opioid analgesic used for the management of moderate to severe pain, including both acute and chronic pain. It was first synthesized in Germany in 1916 from thebaine, an opium alkaloid. Oxycodone acts primarily as an agonist at mu-opioid receptors in the central nervous system, altering the perception and response to pain. It also has activity at kappa and delta opioid receptors. The drug is available in immediate-release and extended-release formulations for oral administration, with onset of action within 15 minutes and duration up to six hours for immediate-release forms. Due to its high potential for addiction, misuse, and dependence, it is classified as a controlled substance[1][4][6][8]. Common side effects include euphoria, constipation, nausea, vomiting, drowsiness, dizziness, itching, dry mouth, sweating; serious risks include respiratory depression and overdose.

Brand names
OxyContinPercodanPercocetDazidoxEndocodoneOxaydoOXECTAOxyIRPercoloneRoxicodoneRoxybond
Other names
羟考酮
02

Targets

KOR (Kappa opioid receptor)DOR (Opioid Receptor Delta 1)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on oxycodone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxycodone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call